Choleresis and inhibition of biliary lipid secretion induced by piperacillin in the rat.
1. The effects of the administration piperacillin on bile flow and biliary lipid secretion were studied in male Wistar rats. 2. Intravenous injection of piperacillin at doses ranging from 0.3 to 3.0 mmol/kg bodyweight led to an increase in its biliary concentration and excretion rate. Maximal biliary excretion was reached at a dose of 2.0 mmol/kg piperacillin. 3. Excretion of the antibiotic into bile was associated with a marked choleresis. A linear relationship was observed between bile flow and piperacillin excretion, 5.7 micro L bile being produced per micro mol piperacillin excreted into the bile. 4. Continuous i.v. infusion of piperacillin at 2.0 mmol/100 g per min did not result in significant changes in bile acid or cholesterol secretion, but biliary phospholipid secretion was markedly reduced. The inhibitory effect on phospholipid secretion was also present when biliary lipid output had been previously increased by an infusion of taurocholate (200 nmol/100 g per min). Addition of taurocholate did not reverse the impairment of phospholipid secretion induced by piperacillin. 5. These results indicate that acute administration of piperacillin in the rat induces a marked choleresis by stimulating bile acid-independent bile flow. The significant impairment in phospholipid secretion suggests a specific effect on intracellular supply and/or translocation across the canalicular membrane.
González
Paquita
P
Department of Physiology, University of León, León. dfimgs@unileon.es
Mauriz
José Luís
JL
Jiménez
Rafael
R
González-Gallego
Javier
J
Tuñón
María Jesús
MJ
D000818:Animals; D001646:Bile / Q000187:drug effects* / Q000378:metabolism*; D001647:Bile Acids and Salts / Q000037:antagonists & inhibitors / Q000378:metabolism; D001652:Bile Ducts; D002784:Cholesterol / Q000378:metabolism; D004305:Dose-Response Relationship, Drug; D050356:Lipid Metabolism; D008055:Lipids / Q000037:antagonists & inhibitors*; D008099:Liver / Q000378:metabolism*; D008297:Male; D010743:Phospholipids / Q000037:antagonists & inhibitors / Q000378:metabolism; D010878:Piperacillin / Q000494:pharmacology*; D051381:Rats; D017208:Rats, Wistar
D001647:Bile Acids and Salts; D008055:Lipids; D010743:Phospholipids; D002784:Cholesterol; D010878:Piperacillin